Our results show that the serum levels of IL-6 were only slightly affected by tumor at day 28, while the serum levels of IFN-γ were not increased, and serum TNF-α was undetectable (data not shown) in 4T1 tumor-bearing mice up to day 28 after tumor cells implantation. The gene discussed is IL6; the disease is neoplasm.